ATAD3A and cancer: This novel molecular reporter endows us to identify novel ATAD3A transcript inhibitors with high confidence, which should interest a range of cancer scientists and clinicians who seek to assess the feasibility of manipulating currently undruggable targets for therapeutic interventions.